Výsledky vyhledávání - "Tumors neuroendocrins

Phase I trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomas

Autor: Martin Wermke, Enriqueta Felip, Valentina Gambardella, Yasutoshi Kuboki, Daniel Morgensztern, Zohra Oum’ Hamed, Meiruo Liu, Matus Studeny, Taofeek K Owonikoko

Publikováno v: Scientia

T-cell engager; Eeuroendocrine carcinoma; Small-cell lung cancer Acoplador de cèl·lula T; Carcinoma neuroendocrí; Càncer de pulmó de cèl·lules petites Acoplador de célula T; Carcinoma neuroendocrino; Cáncer de pulmón de células pequeñas P

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e83791285194b01116298cd0de0ee7c
https://doi.org/10.2217/fon-2022-0196

Zobrazit plný text záznamu

Efficacy of [177Lu]Lu-DOTATATE in metastatic neuroendocrine neoplasms of different locations: data from the SEPTRALU study

Publikováno v: Scientia

Background Peptide receptor radionuclide therapy (PRRT) is one of the most promising therapeutic strategies in neuroendocrine neoplasms (NENs). Nevertheless, its role in certain tumor sites remains unclear. This study sought to elucidate the efficacy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8eb62d000936acca2528550a5d191e47
https://hdl.handle.net/11351/9825

Zobrazit plný text záznamu

Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin

Publikováno v: Scientia

Cancer immunotherapy; Neuroendocrine cancer; Tumour immunology Immunoteràpia del càncer; Càncer neuroendocrí; Immunologia tumoral Inmunoterapia del cáncer; Cáncer neuroendocrino; Inmunología tumoral Single immune checkpoint blockade in advance

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e67fc8c7947b2ba71003b47eeacc269c
https://doi.org/10.1038/s41467-023-38611-5

Zobrazit plný text záznamu

Satisfaction with injection experience of patients with neuroendocrine tumors enrolled on lanreotide autogel patient support programs: Results from the international HomeLAN survey

Autor: Jorge Hernando, Teodora Kolarova, Chris Verslype, Gregory Kaltsas, Aude Houchard, Delphine Gueguen, Wouter W. De Herder

Publikováno v: Journal of Neuroendocrinology. Wiley-Blackwell Publishing Ltd
Scientia

Injection experience; Neuroendocrine tumors; Somatostatin analog Experiència en injecció; Tumors neuroendocrins; Anàleg de la somatostatina Experiencia en inyección; Tumores neuroendocrinos; Análogo de la somatostatina Lanreotide autogel/depot (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d05a9edefabc90b09fc14a39313ca2c
https://pure.eur.nl/en/publications/47fbcc12-995d-4bea-9984-00fecf75eb4f

Zobrazit plný text záznamu

Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours: CLARINET FORTE phase 2 study results

Autor: Philippe Ruszniewski, Tahir Shah, Ulrich Frank Pape, Aude Houchard, Marianne Pavel, C. Lombard-Bohas, Xuan-Mai Truong Thanh, Francesco Panzuto, Ivan Borbath, Jarosław B. Ćwikła, Jaume Capdevila

Publikováno v: Scientia
European journal of cancer (Oxford, England : 1990), Vol. 157, no.157, p. 403-414 (2021)

Lanreotide; Progression-free survival; Somatostatin Lanreótido; Supervivencia libre de progresión; Somatostatina Lanreòtid; Supervivència lliure de progressió; Somatostatina Introduction This prospective, single-arm, phase 2 study assessed the e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d78ade697d46998775c9b6ad82708df
https://doi.org/10.1016/j.ejca.2021.06.056

Zobrazit plný text záznamu

Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects

Autor: Gulde, Sebastian, Foscarini, Alessia, April-Monn, Simon L, Genio, Edoardo, Marangelo, Alessandro, Satam, Swapna, Helbling, Daniel, Falconi, Massimo, Toledo, Rodrigo A, Schrader, Jörg, Perren, Aurel, Marinoni, Ilaria, Pellegata, Natalia S

Publikováno v: Cancers; Volume 14; Issue 22; Pages: 5481
Cancers 14:5481 (2022)
Scientia
Gulde, Sebastian; Foscarini, Alessia; April-Monn, Simon L; Genio, Edoardo; Marangelo, Alessandro; Satam, Swapna; Helbling, Daniel; Falconi, Massimo; Toledo, Rodrigo A; Schrader, Jörg; Perren, Aurel; Marinoni, Ilaria; Pellegata, Natalia S (2022). Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects. Cancers, 14(22) MDPI AG 10.3390/cancers14225481

Buparlisib; Combination therapy; Primary human tumoroids Buparlisib; Terapia de combinación; Tumoroides humanos primarios Buparlisib; Teràpia combinada; Tumoroides humans primaris Pancreatic neuroendocrine neoplasms (PanNENs) are the second most co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2226f2fc67567f4cce2dbb99c6d90e67

Zobrazit plný text záznamu

Plný text ve formátu HTML

The impact of COVID‐19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients

Autor: Mauro Cives, Jorge Hernando, Angela Lamarca, Catherine Bouvier, Martyn Caplin, Marianne Pavel

Publikováno v: Scientia

SARS-CoV-2; Carcinoids; Vaccination SARS-CoV-2; Carcinoides; Vacunación SARS-CoV-2; Carcinoides; Vacunació The COVID-19 outbreak has added complexity in the management of patients with neuroendocrine tumors (NETs). Little information is currently a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a2cab6ab1059093e58b900ca528c820
https://doi.org/10.1111/jne.13196

Zobrazit plný text záznamu

Lurbinectedin in patients with pretreated neuroendocrine tumours: Results from a phase II basket study

Autor: Federico Longo-Muñoz, Daniel Castellano, Jerome Alexandre, Sant P. Chawla, Cristian Fernández, Carmen Kahatt, Vicente Alfaro, Mariano Siguero, Ali Zeaiter, Victor Moreno, Enrique Sanz-García, Ahmad Awada, Ana Santaballa, Vivek Subbiah

Publikováno v: Scientia
European journal of cancer (Oxford, England : 1990)
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Lurbinectedin; Neuroendocrine tumours; Small cell Lurbinectedina; Tumores neuroendocrinos; Célula pequeña Lurbinectedina; Tumors neuroendocrins; Cèl·lula petita Background Patients with neuroendocrine tumours (NETs) need alternative therapies aft

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a1d605cd1021c2a275ca1c4d159c945
https://hdl.handle.net/11351/8198

Zobrazit plný text záznamu

Luteci (177Lu) oxodotreotida per al tractament de tumors neuroendocrins gastroenteropancreàtics positius al receptor de somatostatina, ben diferenciats, progressius i irresecables o metastàtics

Autor: Programa d'Harmonització Farmacoterapèutica

Publikováno v: Scientia
Recercat: Dipósit de la Recerca de Catalunya
Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Recercat. Dipósit de la Recerca de Catalunya
instname

Luteci oxodotreotida; Radiofàrmac; Tumors neuroendocrins gastroenteropancreàtics Lutecio oxodotreotida; Radiofármaco; Tumores neuroendocrinos gastroenteropancreáticos Luteci oxodotreotida; Radiopharmaceutical; Gastroenteropancreatic neuroendocrin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::339d9853d589238d00db7c13f46b9a8d
http://hdl.handle.net/11351/5674

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání